Protein content as a marker for response to therapy in brain cancer

(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists from the German Cancer Research Center (DKFZ) have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news